Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
4.150
+0.570 (15.92%)
At close: Mar 12, 2025, 4:00 PM
4.137
-0.013 (-0.32%)
After-hours: Mar 12, 2025, 4:03 PM EST
Cardiff Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 51.47 | 21.66 | 16.35 | 11.94 | 130.98 | Upgrade
|
Short-Term Investments | 40.28 | 53.17 | 88.92 | 128.88 | - | Upgrade
|
Cash & Short-Term Investments | 91.75 | 74.82 | 105.27 | 140.82 | 130.98 | Upgrade
|
Cash Growth | 22.62% | -28.92% | -25.25% | 7.51% | 1184.72% | Upgrade
|
Accounts Receivable | 0.77 | 0.29 | 0.77 | 0.54 | 0.32 | Upgrade
|
Other Receivables | 0.4 | 0.6 | - | - | - | Upgrade
|
Receivables | 1.17 | 0.89 | 0.77 | 0.54 | 0.32 | Upgrade
|
Prepaid Expenses | 2.14 | 1.7 | 5.25 | 4.77 | 2.06 | Upgrade
|
Total Current Assets | 95.05 | 77.41 | 111.28 | 146.13 | 133.36 | Upgrade
|
Property, Plant & Equipment | 2.07 | 2.95 | 3.52 | 3.18 | 0.97 | Upgrade
|
Other Long-Term Assets | 0.07 | 1.28 | 1.39 | 0.24 | 0.4 | Upgrade
|
Total Assets | 97.19 | 81.64 | 116.19 | 149.54 | 134.73 | Upgrade
|
Accounts Payable | 4.82 | 1.97 | 1.96 | 1.44 | 1.37 | Upgrade
|
Accrued Expenses | 7.9 | 7.78 | 5.18 | 4.11 | 3.46 | Upgrade
|
Current Portion of Leases | 0.71 | 0.69 | 0.68 | 0.55 | 0.86 | Upgrade
|
Other Current Liabilities | - | - | - | 0.46 | 0.43 | Upgrade
|
Total Current Liabilities | 13.43 | 10.44 | 7.81 | 6.56 | 6.12 | Upgrade
|
Long-Term Leases | 0.81 | 1.46 | 2.04 | 2.57 | 0.01 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 0.44 | Upgrade
|
Total Liabilities | 14.24 | 11.9 | 9.85 | 9.13 | 6.57 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 467.09 | 409.34 | 404.83 | 400.5 | 361.82 | Upgrade
|
Retained Earnings | -384.18 | -339.54 | -298.1 | -259.81 | -231.5 | Upgrade
|
Comprehensive Income & Other | 0.03 | -0.07 | -0.4 | -0.28 | -2.17 | Upgrade
|
Total Common Equity | 82.95 | 69.74 | 106.34 | 140.42 | 128.16 | Upgrade
|
Shareholders' Equity | 82.95 | 69.74 | 106.34 | 140.42 | 128.16 | Upgrade
|
Total Liabilities & Equity | 97.19 | 81.64 | 116.19 | 149.54 | 134.73 | Upgrade
|
Total Debt | 1.52 | 2.15 | 2.72 | 3.12 | 0.87 | Upgrade
|
Net Cash (Debt) | 90.22 | 72.67 | 102.55 | 137.7 | 130.11 | Upgrade
|
Net Cash Growth | 24.15% | -29.13% | -25.53% | 5.83% | 1436.34% | Upgrade
|
Net Cash Per Share | 1.89 | 1.63 | 2.35 | 3.53 | 6.23 | Upgrade
|
Filing Date Shares Outstanding | 66.52 | 44.68 | 44.68 | 43.31 | 37.05 | Upgrade
|
Total Common Shares Outstanding | 66.52 | 44.68 | 44.68 | 41.96 | 36.78 | Upgrade
|
Working Capital | 81.63 | 66.97 | 103.48 | 139.57 | 127.24 | Upgrade
|
Book Value Per Share | 1.25 | 1.56 | 2.38 | 3.35 | 3.48 | Upgrade
|
Tangible Book Value | 82.95 | 69.74 | 106.34 | 140.42 | 128.16 | Upgrade
|
Tangible Book Value Per Share | 1.25 | 1.56 | 2.38 | 3.35 | 3.48 | Upgrade
|
Machinery | 2.47 | 2.42 | 2.12 | 1.86 | 1.67 | Upgrade
|
Leasehold Improvements | 2.57 | 2.57 | 2.56 | 1.96 | 1.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.